Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
AstraZeneca Closes Acquisition of Amolyt Pharma
02:00am, Monday, 15'th Jul 2024
LYON, France and CAMBRIDGE, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrin
AstraZeneca has a 'catalyst-rich' period ahead
04:41am, Friday, 12'th Jul 2024
British pharmaceuticals megacap AstraZeneca PLC (LSE:AZN) shares surged nearly a percentage point higher on Friday, reflecting what broker Shroe Capital Markets sees as a “catalyst-rich period ahead
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
03:22pm, Wednesday, 10'th Jul 2024
In my view, it's important for every individual to invest in equities. By just holding cash in a back account, there is bound to be loss of purchasing power when adjusted for inflation.
AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
11:25am, Friday, 05'th Jul 2024
The European Commission approves AstraZeneca's (AZN) Tagrisso in combination with chemotherapy for first-line treatment of advanced EGFR-mutated NSCLC based on data from the phase III FLAURA2 study.
U.K. Top 40 Quality Dividend Stocks: Summer 2024
01:25pm, Wednesday, 03'rd Jul 2024
Unfortunately, UK investors have had to suffer weak or negative capital gains in recent years to get those high yields. The good news is that the UK remains an attractive market for dividend investors
Aptamer Group up 12% on AstraZeneca collaboration
03:31am, Wednesday, 03'rd Jul 2024
Shares of Aptamer Group PLC (AIM:APTA) were up 12% after announcing a new collaboration with AstraZeneca PLC (LSE:AZN) to explore the use of Optimer technology for targeted delivery of siRNA, a type o
AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
12:00pm, Tuesday, 02'nd Jul 2024
The CHMP recommends approval of AstraZeneca's (AZN) Imfinzi plus Lynparza for treating primary advanced or recurrent endometrial cancer based on data from the phase III DUO-E study.
3 Set-It-and-Forget-It Stocks for Lasting Financial Security
10:42am, Tuesday, 02'nd Jul 2024
One of the greatest forces in wealth-building is the power of compounding. That is why every portfolio needs some set-it-and-forget-it stocks.
AstraZeneca's COVID prevention drug application gets EU fast-track assessment
02:24am, Monday, 01'st Jul 2024
AstraZeneca said on Monday the EU drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, Sipavibart, under an accelerated assessment.
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
10:45am, Friday, 28'th Jun 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
German vaccine panel endorses Astra-Sanofi's RSV shot for infants
08:02am, Thursday, 27'th Jun 2024
Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca and Sanofi's antibody therapy to protect them against the common respiratory infecti
7 Biotech Stocks to Boost Your Portfolio to Peak Health
02:11pm, Wednesday, 26'th Jun 2024
While innovations such as artificial intelligence have become all the rage, there's another type of technology – biotechnology – that deserves careful consideration for your portfolio. Indeed, if
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
02:01pm, Wednesday, 26'th Jun 2024
Data from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy before and after bladder removal surgery improves survival in patients.
Healthcare: Best strategies to invest in pharma stocks
11:55am, Wednesday, 26'th Jun 2024
Novo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as their approval in China. While these names
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
03:04am, Wednesday, 26'th Jun 2024
China has approved the use of AstraZeneca's blockbuster cancer drug Tagrisso in combination with chemotherapy as a first line of treatment for adults with a type of advanced lung cancer, the company s
